Skip to main content
Clinical Trials/NCT02408679
NCT02408679
Completed
Not Applicable

A Study to Validate a Predictive Questionnaire for Vitamin D Insufficiency in Healthy Adults

Lesieur1 site in 1 country300 target enrollmentJanuary 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy Volunteers
Sponsor
Lesieur
Enrollment
300
Locations
1
Primary Endpoint
Questionnaire internal validity
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this clinical study is to evaluate the metrological properties of a questionnaire that aims to identify the vitamin D status in reference to a vitamin D blood dosage.

Detailed Description

Each subject will perform only one visit (visit V1). The study duration per subject will last about 2 hours. During this visit V1, the subjects will perform a medical exam in order to check their eligibility (general statement and check of inclusion / non-inclusion criteria). The eligible subjects will fill up a study questionnaire and will perform a blood sampling for a dosage of serum vitamin D.

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
February 2015
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Lesieur
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male and female volunteers
  • Subject able to communicate with the investigator and the study team, able to read and write and follow all study instructions.
  • Written informed consent provided and signed prior screening, after receiving and understanding the subject information.
  • Registered with the French Social Security, in agreement with the French law on biomedical experimentation.

Exclusion Criteria

  • Subject with diagnosed osteoporosis, osteopenia or osteomalacia.
  • Subject with known disease that contributes in osteoporosis: Rheumatoid arthritis, Malabsorption syndrome, Inflammatory bowel disease, Hyperthyroidism, Hyperparathyroidism.
  • Subject with known hepatic impairment.
  • Subject with known liver impairment or with a history of renal transplantation.
  • Subject with history of cancer.
  • Subject with history of bariatric surgery.
  • Subject taking or having taken osteoporosis inducing treatment, or treatment with an effect on calcium and phosphorus metabolism during the 3 months prior the visit: Corticosteroids, Enzyme inducing anticonvulsants, Heparin.
  • Subject requiring vitamin D supplementation for a diagnosed pathology.
  • Pregnant or breastfeeding Female.
  • Subject with history of alcohol or drug abuse.

Outcomes

Primary Outcomes

Questionnaire internal validity

Time Frame: Day 1

Evaluation of the internal coherence and factorial structure of the questionnaire, establishment of scoring rules

Questionnaire external validity

Time Frame: Day 1

Prediction of the vitamin D status (threshold value, sensitivity, specificity for vitamin D insufficiency; threshold value, sensitivity, specificity for vitamin D deficiency)

Confounding factors (demographic data)

Time Frame: Day 1

Interests for coupling the study questionnaire and demographic data (age, gender, Body Mass Index, phototype).

Study Sites (1)

Loading locations...

Similar Trials